This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Genetics  • Genetic Disorders  • Neurology  • Glaucoma  • Pediatric Ophthalmology  • Retinal Detachment  • Alert me on articles by topic

Carol L. Shields, MD; Jonathan Zahler, DO; Naomi Falk, OD, MD; Minoru Furuta, MD; Ralph C. Eagle Jr, MD; Luis E. Bello Espinosa, MD; Philip R. Fischer, MD; Jerry A. Shields, MD

Arch Ophthalmol. 2007;125(6):840-842.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant muscular dystrophy estimated to affect 1 in 20 000 white persons. The clinical features of this condition range from minimally detectable myopathy to severe disability. There is a characteristic pattern of weakness that affects predominantly the face (facio) and shoulder (scapulohumeral) muscles and later descends inferiorly to the abdomen and the legs.^1-3 Symptoms become manifest in the teen years to early adulthood and progress slowly. Recent studies have shown a characteristic deletion in the long arm of chromosome 4 (4q35),² but the exact mechanism of this disease remains unknown.

Classic Coats disease is a congenital, idiopathic retinal telangiectasia that can progress to severe retinal exudation and detachment.⁴ Retinal . . . [Full Text of this Article]

Report of a Case


Comment

AUTHOR INFORMATION

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Detection of Facial Hypotonia and Diagnosis of Facioscapulohumeral Dystrophy--Reply
Shields et al.
Arch Ophthalmol 2008;126:746-746.
FULL TEXT  

Detection of Facial Hypotonia and Diagnosis of Facioscapulohumeral Dystrophy
Sheth and Shapiro
Arch Ophthalmol 2008;126:745-746.
FULL TEXT